| Martin D White, MD | |
|
25 N Winfield Rd, Winfield, IL 60190-1379 | |
| (630) 933-4700 | |
| (630) 933-4427 |
| Full Name | Martin D White |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | 25 N Winfield Rd, Winfield, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821432261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 036142446 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Dupage Physician Group | 5890696231 | 1003 |
News Archive
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
› Verified 3 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martin D White, MD 25 N Winfield Rd, Winfield, IL 60190-1379 Ph: (630) 933-4700 | Martin D White, MD 25 N Winfield Rd, Winfield, IL 60190-1379 Ph: (630) 933-4700 |
News Archive
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
› Verified 3 days ago
Timothy R Long, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Sarah Jaber, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Ms. Julia Kochel Hernandez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Ste 400, Winfield, IL 60190 Phone: 630-469-9200 | |
Lipi Mehul Sekhadia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 | |
Dr. Nicolai E Hinds, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-653-4240 Fax: 630-315-6597 | |
Priya Venkataraman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 | |
Dr. Sana Sajid Chaudhry, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 400, Winfield, IL 60190 Phone: 630-456-7178 Fax: 630-456-7486 |